Cedar Health Research, a Texas-based clinical trial network focused on underserved patients, and Texas Native Health, a Dallas nonprofit serving American Indian and Alaska Native communities, announced on Wednesday that they have opened a new embedded Cedar Health Research site within Texas Native Health.
Established in 2023, the collaborative partnership aims to expand access to clinical research for Native American patients, a population that has historically been underrepresented in clinical trials.
The integrated site allows patients to participate in studies within their trusted care setting, reducing barriers such as travel, limited culturally informed study designs, and longstanding underrepresentation in clinical data.
Initially, the site will support studies addressing conditions disproportionately affecting Native American populations, such as cardiometabolic diseases. Native Americans are 36% more likely than the general US population to have diabetes, and approximately 50% of Native American adults are obese.
Nucleome Therapeutics names new chief scientific officer
Celltrion data show subcutaneous infliximab restores disease control after treatment interruption
Cambridge Cognition expands into India through Ivory commercialisation agreement
Genentech reports positive Phase III MAJESTYdata for Gazyva in primary membranous nephropathy
Ella immunoassay platform gains CE‑IVD approval in the EU
HanchorBio's HCB101 receives US FDA Orphan Drug Designation in gastric cancer
MEDIPOST files IND amendment to start Phase III trial for knee osteoarthritis therapy
AstraZeneca reports positive Phase III results for BREZTRI in uncontrolled asthma
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
Amgen wins European approval for Uplizna in generalised myasthenia gravis